1.Epoprostenol: Flushing or Erythroderma?.
Maria Luisa MARTINEZ-MARTINEZ ; Eduardo ESCARIO-TRAVESEDO ; Ana NUNEZ-ARES ; Syong Hyun NAM-CHA ; Maria RODRIGUEZ-VAZQUEZ ; Juan Gabriel CORDOBA-SORIANO ; Rafaela SANCHEZ-SIMON-TALERO
Annals of Dermatology 2013;25(2):271-272
No abstract available.
Flushing
2.Hiccups, facial flushing and hypertension after lumbar epidural steroid injection: A case report.
Seon jin KIM ; Eun Ju KIM ; Byung woo MIN ; Jong Seouk BAN ; Sang Gon LEE ; Ji hyang LEE
Anesthesia and Pain Medicine 2011;6(2):118-120
Epidural steroid injections (ESI) are commonly used for managing radicular pain. They are generally considered to be a safe treatment with a low incidence of complications, which may be very mild and transient symptoms. We describe here one case of a delayed onset of hiccups, facial flushing and hypertension associated with a lumbar epidural steroid injection.
Flushing
;
Hiccup
;
Hypertension
;
Incidence
3.Hiccups, facial flushing and hypertension after lumbar epidural steroid injection: A case report.
Seon jin KIM ; Eun Ju KIM ; Byung woo MIN ; Jong Seouk BAN ; Sang Gon LEE ; Ji hyang LEE
Anesthesia and Pain Medicine 2011;6(2):118-120
Epidural steroid injections (ESI) are commonly used for managing radicular pain. They are generally considered to be a safe treatment with a low incidence of complications, which may be very mild and transient symptoms. We describe here one case of a delayed onset of hiccups, facial flushing and hypertension associated with a lumbar epidural steroid injection.
Flushing
;
Hiccup
;
Hypertension
;
Incidence
5.Determination of flushing volume in cannine orthotopic liver transplantation.
Jung Kee CHUNG ; Oh Joong KWON ; In Kyu HONG ; Gil Joon SUH ; Woo Ryong LEE ; Eui Chan CHANG ; Kyung Suk SUH ; Sang Joon KIM ; Soo Tae KIM ; Jin Kyu KIM
The Journal of the Korean Society for Transplantation 1991;5(1):151-156
No abstract available.
Flushing*
;
Liver Transplantation*
;
Liver*
6.A Randomised, Double-Blind, Parallel, Placebo-Controlled Study of the Efficacy and Safety of Tadalafil Administered On-Demand to Men with Erectile Dysfunction in Korea.
Hyung Ki CHOI ; Je Jong KIM ; Sae Chul KIM ; JunKyu SUH ; Yoon Kyu PARK ; Seong CHOI ; Woong Hee LEE ; Ki Hak MOON ; Hae Young PARK ; Jong Kwan PARK ; Wei Christine WANG ; Vladimir KOPERNICKY
Korean Journal of Urology 2006;47(8):852-858
PURPOSE: Tadalafil is a phosphodiesterase type 5 inhibitor that is used for the treatment of erectile dysfunction (ED). Previous clinical trials have assessed its efficacy and safety in Western populations, but this drug has not been investigated in a large clinical trial involving Korean men with ED. Thus, the aim of this study was to assess the efficacy and safety of 20 mg tadalafil in comparison to placebo when it is taken on demand by Korean men suffering with ED over a study period of 12 weeks. MATERIALS AND METHODS: Men more than 18 years of age with mild to severe ED of various etiologies were randomized to receive placebo or tadalafil 20 mg that was taken as needed (maximum once daily). Efficacy assessments included the International Index of Erectile Function (IIEF), the Sexual Encounter Profile (SEP) diary and Global Assessment Questions (GAQ). RESULTS: Tadalafil significantly improved erectile function, as measured by the erectile function domain of the IIEF, compared to placebo (p<0.001). At the endpoint, the patients receiving tadalafil 20mg reported a greater mean per-patient percentage of successful intercourse attempts (SEP3: 71% compared to 31% for placebo) and a greater proportion of improved erections (GAQ: 80% compared to 44%). The most common treatment emergent adverse events were headache (16.3%), flushing (5%) and eye pain (5%), and most of the adverse events were mild or moderate in severity. CONCLUSIONS: Tadalafil was an effective, well-tolerated therapy for Korean men suffering with ED of broad-spectrum severity and etiology.
Erectile Dysfunction*
;
Eye Pain
;
Flushing
;
Headache
;
Humans
;
Korea*
;
Male
;
Tadalafil
7.Clinical Observation on Antihypertensive Effects of Nicardipine Hydrochloride(Perdipine(R)).
Wang Seong RYU ; Byung Heui OH ; Myoung Mook LEE ; Jung Don SEO ; Young Woo LEE
Korean Circulation Journal 1985;15(4):659-663
The antihypertensive effect of nicardipine was studied in 31 cases of essential hypertension and following results were obtained. 1) Daily dose was 30-60mg for 10 weeks. 2) Mean systolic and diastolic pressure were decreased by 39.5mmHg 921%) and 17.2mmHg(15%) respectively(P<0.005) and in 84% of cases, good or fair control of blood pressure was proved. 3) There was no significant change in heart rates before and after treatment. 4) There were no significant side effects except two cases of mild headache and facial flushing which subsided spontaneously.
Blood Pressure
;
Flushing
;
Headache
;
Heart Rate
;
Hypertension
;
Nicardipine*
8.Hypotensive Efficacy and Safety of Manidipine on the Patient with Essential Hypertension.
Won Sang YOO ; Young Bin JEON ; Sang Hyun PARK ; Chang Young LIM ; Suck Koo CHOI
Korean Circulation Journal 1991;21(2):350-355
Thirty patient with essential hypertension were administered Manidipine, a new calcium antagonist, 10~20mg once daily to evaluate the hypotensive efficacy and safety for 8 weeks. And the followings were the result. 1) Patients were consists of 14 male, 16 female, aged 53 in average and classified as mild in 21 and moderate in 9 patients. 2) Optimum intial dose was 10mg and 10 to 20mg were the doses recommended. 3) Blood pressure dropped after 8 weeks 24/13mmHg in average, rewarding 80% effectiveness and normalized in 87%. 4) Most frequent side reaction was facial flushing in 5 patiens followed by palpitation and dizziness, all of which did not disturb the continuation of medication. 5) Most of routine laboratory parameter were normal and unchanged between before and after the trial. 6) Overall rating of usefulness was 77%. In conclusion, Manidipine 10 to 20mg once daily regimen is well tolerated and effective in the treatment of mild to moderate essential hypertension.
Blood Pressure
;
Calcium
;
Dizziness
;
Female
;
Flushing
;
Humans
;
Hypertension*
;
Male
;
Reward
9.Therapeutic Continuous Irrigation Via Indwelling Catheter for the Neurosurgical Infections.
Dong Been PARK ; Sang Yong LEE ; Yung Rak YOO ; Nam Kyu KIM ; Hwan Yung CHUNG
Journal of Korean Neurosurgical Society 1977;6(2):419-426
It is the fact that parenteral antobiotics have no place in the treatment of the discitis after postoperative state because the antobiotics can not reach the focus of infection on account of the avascular zone of the intervetebral space. The author treats more extensive discitis to place an indwelling rubber catheter into the cavity to a contunuous irrigation with normal saline solution containing antobiotics. The catheter is left are as following ; 1. It is to effect the continuous direct administration of the antobiotics. 2. It is a mechnical effect by flushing out necrotic particles. 3. It is less recurrent infection. 4. The method is very simple, inexpensive. 5. The treated period is very short in contrast with immobilization and systemic antibacterial administration.
Catheters
;
Catheters, Indwelling*
;
Discitis
;
Flushing
;
Immobilization
;
Rubber
;
Sodium Chloride
10.A Change of Blood Pressure with Varying Rates of Administration of d-Tuboeurarine and Antihistamine Premedication .
Kyung Kil CHO ; Jong Hak KIM ; Jae Bong LEE ; Young Soon LAU ; Eui Hum JUNG ; Won Jin KIM ; Chung Hyun CHO
Korean Journal of Anesthesiology 1982;15(3):270-273
Direct arterial pressure(DAP) and heart rate were observed in normal patients during and after intravenous injection of d-Tc at varying rates of administration. The injection of d-Tc was preceeded by antihistmine(hydroxysine) in group ll. The results were as follows: 1) Alteration of pulse rate was minimal following varied administration of d-Tc in all groups. 2) DAP showed maximal change following a bolus injection of d-Tc, and a minimal change at the end of 180 seconds of d-Tc administration. 3) DAP showed minimal change following the premediction with antihistamine in comparison to a bolus administration. 4) Manifestation of flushing and tachycardia due to histmine release were not observed in group l and group ll.
Blood Pressure*
;
Flushing
;
Heart Rate
;
Humans
;
Injections, Intravenous
;
Premedication*
;
Tachycardia